To test a potential correlation between STAT5 expression levels and the frequency of BCR-ABL1 mutations we decided to analyse leukemic samples from a cohort of 50 CML patients including our initial patient sample collection [30] (For patient characteristics see Table 1). The gene discussed is STAT5B; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.